Menu Back to Patient-Engagement

Patient Engagement eLearning Program

Gain an Understanding of Patient Engagement in Drug Development.

An ever-expanding area of collaboration is occurring between patients, patient organizations, industry, regulators, and governmental organizations to ensure that new drugs developed both represent value to the patients they aim to treat, and that the timeframe for providing new innovations to patients is accelerated. Integrating the patient experience from the early stages of drug development through approval and post-marketing is now an accepted norm. However, for many companies, understanding why this is important as well as convincing leadership to invest in these activities can be confusing and elusive. These courses provide fundamentals about why and how to build such a function.


Introduction to Patient Engagement in Drug Development

This module is designed to provide the foundational knowledge for integrating the patient perspective into the full medicines lifecycle, including regulatory decision making and post-marketing efforts, which can improve patient outcomes and increase the success of the product. The concepts covered in this course apply to drugs, biologics, devices, and any medical/therapeutic products developed for patient use.

Learning Objectives

Upon completion of this module, learners should be able to:

  • Describe why integration of the patient perspective is integral for drug development programs
  • Explain how other companies have executed and benefited from such programs
  • Explain, from a patient point of view, what constitutes meaningful engagement
  • List steps a company can take to build a culture of patient engagement, and what resources exist to help
Module Duration: 1 hour.

Add to Cart


Preparing for Purposeful Patient Organization Partnerships

The 5 W's: Why? Who? When? What? hoW?

There has never been more interest in fostering fruitful partnerships between life science companies and patient organizations. As with any new endeavor, before you get started it’s prudent to gain an understanding of the terrain of patient advocacy communities, changing capacities and expectations, and emerging best practices. This module provides an overview of different organizational types, how to identify and gauge potential partners, when to engage, what might be gained from partnerships, and guiding principles to maximize shared success.

Learning Objectives

Upon completion of this module, learners should be able to:

  • Explain the rationale for partnering with patients
  • Describe different types of patient organizations and existing resources to help identify those whose objectives and capabilities are best positioned to align with stated project goals
  • List factors to consider in timing the approach to patient organizations
  • Draw upon existing open source resources to reduce uncertainty about terms of and conditions for partnering activities
  • Identify criteria for meaningful, quality engagements with patient organizations to guide interactions and contracting
  • List common challenges with partnering with patient organizations and ways to mitigate them
Module Duration: 3 hours.

Add to Cart


Legal and Compliance Considerations for Engaging Patients As Partners

While there is much accumulated experience with and well-established procedures and contracting processes for engaging academic and medical experts in the work of life science companies, patients, care partners, and patient advocates bring a different type of expertise to and expectations for interactions. This course will review ethical, legal, and regulatory requirements for patient contact and engagement, as well as emerging points of consensus about fair practices for engaging patients, care partners, and patient advocates, including non-disclosure, privacy, compensation, non-exclusivity, and independence.

Learning Objectives

Upon completion of this module, learners should be able to:

  • Discuss the legal, ethical, and regulatory requirements and considerations for patient engagement and contact.
  • Recognize standard contracting terms used for other types of KOLs that can present challenges when engaging patient/care partner/advocate expertise.
  • Explain how to integrate emerging best practices for contracting with patients/care partners/advocates into your company’s planning and processes.
  • Describe appropriate expectations for compliance with current legal and regulatory requirements for engaging and contacting patients/care partners/advocates.
Module Duration: 1.75 hours.

Add to Cart

Monitor the website for additional modules in this program coming soon!



Patient Engagement On-Demand Subscription

In 2006, DIA was among the first organizations to recognize the importance of patient involvement in drug development and launched its first Patient Fellowship Program. Since then, the role patients can play in therapeutic product R&D has exploded. DIA continues to lead the way, providing input and insights into the evolution of patient engagement throughout the therapeutic product development lifecycle, and driving towards improved health and well-being throughout the world.

Throughout the year, new recordings and relevant content will be added as they become available. Purchase a one year subscription to get access to this library of dynamic, on-demand content. Get the information you need anywhere, anytime, on any device.

Add to Cart